PubMed:18674790 / 89-222 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T2","span":{"begin":0,"end":133},"obj":"Sentence"}],"text":"Often, chemotherapy by doxorubicin (Adriamycin) is limited due to life threatening cardiotoxicity in patients during and posttherapy."}

{"project":"LitCoin-entities","denotations":[{"id":"5386","span":{"begin":23,"end":34},"obj":"ChemicalEntity"},{"id":"5387","span":{"begin":36,"end":46},"obj":"ChemicalEntity"},{"id":"5388","span":{"begin":83,"end":97},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A6","pred":"db_id","subj":"5386","obj":"MESH:D004317"},{"id":"A7","pred":"db_id","subj":"5387","obj":"MESH:D004317"},{"id":"A8","pred":"db_id","subj":"5388","obj":"MESH:D066126"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Often, chemotherapy by doxorubicin (Adriamycin) is limited due to life threatening cardiotoxicity in patients during and posttherapy."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T2","span":{"begin":51,"end":58},"obj":"GeneOrGeneProduct"}],"text":"Often, chemotherapy by doxorubicin (Adriamycin) is limited due to life threatening cardiotoxicity in patients during and posttherapy."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T5","span":{"begin":51,"end":58},"obj":"GeneOrGeneProduct"}],"text":"Often, chemotherapy by doxorubicin (Adriamycin) is limited due to life threatening cardiotoxicity in patients during and posttherapy."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T3","span":{"begin":83,"end":97},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A3","pred":"originalLabel","subj":"T3","obj":"D066126"}],"text":"Often, chemotherapy by doxorubicin (Adriamycin) is limited due to life threatening cardiotoxicity in patients during and posttherapy."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T3","span":{"begin":83,"end":97},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A3","pred":"ID:","subj":"T3","obj":"D066126"}],"text":"Often, chemotherapy by doxorubicin (Adriamycin) is limited due to life threatening cardiotoxicity in patients during and posttherapy."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T3","span":{"begin":83,"end":97},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A3","pred":"#label","subj":"T3","obj":"D066126"}],"text":"Often, chemotherapy by doxorubicin (Adriamycin) is limited due to life threatening cardiotoxicity in patients during and posttherapy."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T4","span":{"begin":23,"end":34},"obj":"ChemicalEntity"},{"id":"T7","span":{"begin":36,"end":46},"obj":"ChemicalEntity"}],"attributes":[{"id":"A4","pred":"ID:","subj":"T4","obj":"D004317"},{"id":"A5","pred":"ID:","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_64816"},{"id":"A6","pred":"ID:","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_28748"},{"id":"A7","pred":"ID:","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_28748"}],"text":"Often, chemotherapy by doxorubicin (Adriamycin) is limited due to life threatening cardiotoxicity in patients during and posttherapy."}

{"project":"LitCoin-NCBITaxon-2","denotations":[{"id":"T2","span":{"begin":101,"end":109},"obj":"OrganismTaxon"}],"text":"Often, chemotherapy by doxorubicin (Adriamycin) is limited due to life threatening cardiotoxicity in patients during and posttherapy."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T7","span":{"begin":36,"end":46},"obj":"ChemicalEntity"},{"id":"T4","span":{"begin":23,"end":34},"obj":"ChemicalEntity"},{"id":"T4968","span":{"begin":83,"end":97},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T88270","span":{"begin":101,"end":109},"obj":"OrganismTaxon"}],"attributes":[{"id":"A7","pred":"ID:","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_28748"},{"id":"A6","pred":"ID:","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_28748"},{"id":"A5","pred":"ID:","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_64816"},{"id":"A4","pred":"ID:","subj":"T4","obj":"D004317"},{"id":"A98859","pred":"#label","subj":"T4968","obj":"D066126"}],"text":"Often, chemotherapy by doxorubicin (Adriamycin) is limited due to life threatening cardiotoxicity in patients during and posttherapy."}